The MIDC and ScienceAbroad, the organization of Israeli scientists abroad, jointly present a revealing program on the bio-tech entrepreneurial ecosystem of Israel and how it created “The Startup Nation,” featuring prominent Israeli scientific and entrepreneurial leaders.
Wednesday, Nov. 1st 5:30-7:30 p.m., Hosted by LifeBridge Health, Baltimore, MD
Thursday, Nov. 2nd 5:30-7:30 p.m., Suburban Hospital, Bethesda, MD
When: October 25, 2017 7:30 AM – 12 PM
Where: MITRE 7525 Colshire Drive McLean, VA 22102 United States
The Technology Showcase emphasizes the National Capital area’s culture of technology innovation and leadership. The conference also highlights Washington’s unique competitive advantage for commercial technology companies: access to policy-makers, government technology buyers, and national security services.
Health Canada has approved the probiotic Visbiome as a Natural Health Product for treating symptoms of irritable bowel syndrome in adults and children aged older than 5 years, the manufacturer announced.
Emergent BioSolutions Inc. (EBS) today announced that it has completed a new five-year, $200 million syndicated senior secured credit facility. This new facility replaces and represents an increase from the Company’s prior $100 million facility, which was scheduled to expire in December 2018. The new facility enhances the Company’s financial flexibility, providing increased capacity to drive growth through strategic acquisitions along with working capital as needed.
This Funding Opportunity Announcement is a Broad Agency Announcement (BAA). It is continuously open for a 5-year period, from October 1, 2017 through September 30, 2022, 11:59 p.m. Eastern Time.
The USAMRMC mission is to provide solutions to medical problems of importance to the American Service member at home and abroad, as well as to the general public at large.
Next month, we will start a series of workshops for academic scientists. If you always wanted to learn Organ-on-a-Chip techniques, you can now do so, straight from the developers, in just two days. You’ll return with two OrganoPlates®, to get you started in the comfort of your own lab.
Our colleague Karlijn Wilschut developed a method for high-content analysis of 3D neurons in the OrganoPlate®, in collaboration with Molecular Devices. This excellent application note is the result.
REGENXBIO Inc. (Nasdaq:RGNX) today announced that Dimension Therapeutics, Inc. (Nasdaq:DMTX) notified REGENXBIO that it has determined that it has received a “superior proposal” as defined in the merger agreement under which REGENXBIO would have acquired Dimension in an all-stock transaction for an implied value of approximately $3.41 per share based on the closing stock price of REGENXBIO stock on August 24, 2017.
CureSearch for Children’s Cancer announced the application launch for a $2 million to $5 million (USD) Catapult Impact Fund Award opportunity. The award will support the advancement of clinical research to improve outcomes for pediatric cancer patients.
Johns Hopkins Technology Ventures kicked off its inaugural cohort of healthcare startups last month with a focus on connected health and fitness. Called M-1 Ventures, a reference to first-year medical students, the accelerator represents a change of strategy for cultivating early stage companies. Although Johns Hopkins previously collaborated with Dreamit Ventures, it was interested in developing an accelerator on its own. To that end it formed regional alliances with the University of Maryland, Village Capital., and the family office of Baltimore-based Under Armour CEO and Chairman Kevin Plank — Plank Industries.
Sisu Global Health is entering product launch phase in a pair of African countries.
The company recently received regulatory clearance to sell its blood transfusion device in Kenya and Ghana, CEO Carolyn Yarina said.
